» Articles » PMID: 24460295

Pancreatic Cancer Incidence and Mortality Patterns in China, 2009

Overview
Specialty Oncology
Date 2014 Jan 28
PMID 24460295
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the incidence and mortality rates for pancreatic cancer in China.

Methods: After checking and reviewing the cancer registry data in 2009 from 72 cancer registry centers, we divided cancer registry areas into urban and rural areas. Incidence/mortality rates, age-specific incidence/mortality rates, age- standardized incidence/mortality rates, proportions, and cumulative incidence/mortality rates for pancreatic cancer were calculated.

Results: The total number of newly diagnosed pancreatic cancer cases and deaths in 2009 were 6,220 and 5,650, respectively. The crude incidence rate in all cancer registry areas was 7.28/100,000 (males 8.24, females 6.29). The age-standardized incidence rate by Chinese standard population (ASR) was 3.35/100,000, with ranking at 7th among all cancers. Pancreatic cancer incidence rate was 8.19/100,000 in urban areas whereas it was 5.41/100 000 in rural areas. Cancer mortality rate in all cancer registry areas was 6.61/100,000 (males 7.45; females 5.75), with ranking at 6th among all cancers, and 7.42/100 000 in urban but 4.94/100000 in rural areas.

Conclusions: Pancreatic cancer incidence and mortality rates have shown a gradual increase in China. Owing to the difficulty of early diagnosis, identification of high-risk population and modification of risk factors are important to reduce the burden of pancreatic cancer.

Citing Articles

Pancreatic cancer incidence and mortality patterns in 2006-2015 and prediction of the epidemiological trend to 2025 in China.

Yin M, Xi L, Liu L, Zhu J, Qian L, Xu C World J Clin Cases. 2022; 10(14):4404-4413.

PMID: 35663052 PMC: 9125275. DOI: 10.12998/wjcc.v10.i14.4404.


The Potential Therapeutic Role of Exosomal MicroRNA-520b Derived from Normal Fibroblasts in Pancreatic Cancer.

Shi H, Li H, Zhen T, Dong Y, Pei X, Zhang X Mol Ther Nucleic Acids. 2020; 20:373-384.

PMID: 32200272 PMC: 7090279. DOI: 10.1016/j.omtn.2019.12.029.


Temporal trends of incidence and mortality in Asian-Americans with pancreatic adenocarcinoma: an epidemiological study.

Gad M, Gaman M, Saad A, Al-Husseini M, Shehata O, Saleh M Ann Gastroenterol. 2020; 33(2):210-218.

PMID: 32127743 PMC: 7049244. DOI: 10.20524/aog.2020.0450.


Spatial distribution and clusters of pancreatic cancer mortality in Shandong Province, China.

Jiang F, Chu J, Chen X, Zhang J, Fu Z, Sun J Sci Rep. 2019; 9(1):12917.

PMID: 31501496 PMC: 6733872. DOI: 10.1038/s41598-019-49357-w.


Meta‑analysis of current chemotherapy regimens in advanced pancreatic cancer to prolong survival and reduce treatment‑associated toxicities.

Chen J, Chen L, Yu J, Xu Y, Wang X, Zeng Z Mol Med Rep. 2018; 19(1):477-489.

PMID: 30431091 PMC: 6297739. DOI: 10.3892/mmr.2018.9638.